In the medicinal product in the form of a solution for injection, visible crystals of unidentified origin were found, probably formed by crystallization of the active substance, which may result in an incorrect dose content and the crystals entering the patient’s bloodstream. Potential effects: cytostatic poisoning, lack of efficacy or thromboembolic complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Cytostin from batch I23H024A; pharmacies and wholesalers should immediately withdraw it from use and return it to the supplier. If a product from this batch has been administered, the patie...
The Chief Pharmaceutical Inspector withdrew Cytostin batch I23H024A from the market nationwide and prohibited its placing on the market, granting the decision immediate enforceability. The wholesaler ...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related